Introduction
Herpes simplex virus (HSV) infection is a common and usually benign, self-limiting disease, which normally presents with mucocutaneous lesions and mild viremia, although the primary HSV infection can cause rather severe local infection [1] .
Occasionally, HSV is associated with severe life-threatening or fatal infection by disseminating to visceral organs. Herpes simplex hepatitis is a well-known clinical condition described in the pediatric population and pregnant women. In adults, systemic herpes simplex with acute hepatitis is a rare complication of HSV infection. It occurs in two distinct adult populations:
immunocompromised adults and pregnant women in the late second or third trimester [2, 3] .
Early diagnosis may be difficult when the characteristic vesicular rash is absent, early symptoms are often nonspecific, and there is a lack of history of genital herpes infection [4, 5] . Here, we present a female patient with hepatitis induced by HSV. We initiated intravenous (IV) acyclovir at a high dose early in the course of the disease. Rapid initiation of IV acyclovir enabled successful treatment, and the patient recovered well.
Case
A 33-year-old woman was admitted to the hospital owing to right upper quadrant abdominal pain and general weakness for three days. The patient had a medical history of breast cancer 10 years ago and a 10-year history of diabetes mellitus, for which she had been taking oral anti-hyperglycemic medications.
On admission, vital signs were as following: blood pressure, 115/86 mmHg; heart rate, 131 beats/min; respiratory rate, 20 breaths/min; and body temperature, 37. Herpes simplex viruses (HSVs) are the most common cause of mucocutaneous infections with dissemination to visceral organs. HSV-induced hepatitis is a rare but frequent cause of hepatitis in immunocompromised patients, pregnant women, and newborns. However, diagnosis is often difficult because the clinical features are nonspecific. In addition, the HSV-related mortality rate is high. Signs and symptoms of HSV include fever, anorexia, nausea, vomiting, abdominal pain or tenderness, leukocytopenia, coagulopathy, and an increase in serum transaminase levels without jaundice. We present a patient who did not correspond to the above symptoms, but survived following prompt intravenous high-dose acyclovir provided early in the course of the disease. and the results of viral cultures were negative (Fig. 3) . In axial view, it shows a small amount of ascites, diffuse heterogeneous enhancement of the liver with a few tiny small nodules.
Herpes Simplex Virus Hepatitis
Although her liver biopsy did not reveal HSV, she completed a 2-week course of IV acyclovir treatment and survived. She was discharged without further treatment and did not experience any recurrence during follow-up in our outpatient department (Fig. 4) .
Discussion
HSV hepatitis is rare and accounts for only 1% of all acute liver failure cases and only 2% of all viral causes of acute liver failure [4] [5] [6] . Several risk factors are associated with the development of HSV hepatitis, including burns, cancer, pregnancy, or immune-modulation drugs: the similarity in each of these conditions is that the host immune defenses are compromised [7] .
As HSV hepatitis is associated with high mortality, exceeding 80%-90%, it seems reasonable to urge early aggressive diagnosis and antiviral therapy, even in the absence of characteristic mucocutaneous ulcerative lesions [8] .
Diagnosis is often difficult to establish because of the lack of specific symptoms and the absence of typical herpetic lesions, as was the case in the patient. Clinical manifestations are nonspecific acute symptoms, which include flu-like illness, fever, and abdominal discomfort with rapid progression to hepatic necrosis and coma [1, 5] . Laboratory investigations often show leukopenia, thrombocytopenia, and coagulopathy. Renal failure occurs in up to 65% of patients with HSV-related acute liver failure.
Moreover, disseminated intravascular coagulopathy is a late sign of the disease. Ninety percent of patients with HSV hepatitis have a characteristic liver profile, known as "anicteric hepatitis," which refers to a liver profile showing a significant increase in transaminases (100-1,000 fold) with relatively normal or low bilirubin [4] . There may be a marked elevation of AST, greater than that of ALT [4, 5] .
Prompt diagnosis of non-acetaminophen fulminant hepatic failure should not only include studies of common hepatitis viruses such as hepatitis A and B, Epstein-Barr virus, and cytomegalovirus, but also HSV [4] .
Seventy-two percent of patients have identifiable mucocutaneous lesions, yet herpes hepatitis was only considered in the differential diagnosis in up to 33% of patients [8] . These lesions should be subjected to smear examination for giant cells and culture tests for viruses. Liver biopsy should be undertaken without delay because antiviral therapy changes may result in loss of typical viral inclusion bodies [8] . Liver biopsy is the gold standard diagnostic method, but owing to the low level of suspicion and the high risk of bleeding caused by prolonged prothrombin time, it was performed in only one-third of the patients [9] . However, the value of liver biopsy may help in confirming suspected HSV hepatitis. The current patient received early empirical treatment with acyclovir with HSV hepatitis. This case clearly illustrates how prompt therapy can positively affect the hospital course of the The present case describes a non-immunocompromised, nongravid adult patient who was diagnosed with HSV hepatitis.
Although HSV hepatitis is associated with high mortality, early initiation of acyclovir might have been lifesaving in this case.
Accordingly, HSV must be considered in all patients presenting with liver failure of unknown cause. If suspected, prompt treatment with acyclovir should be initiated early and rapidly.
